Literature DB >> 9153424

Mechanisms of stabilization of the insulin hexamer through allosteric ligand interactions.

S Rahuel-Clermont1, C A French, N C Kaarsholm, M F Dunn, C I Chou.   

Abstract

The insulin hexamer is an allosteric protein capable of undergoing transitions between three conformational states: T6, T3R3, and R6. These transitions are mediated by the binding of phenolic compounds to the R-state subunits, which provide positive homotropic effects, and by the coordination of anions to the bound metal ions, which act as heterotropic effectors. Since the insulin monomer is far more susceptible than the hexamer to thermal, mechanical, and chemical degradation, insulin-dependent diabetic patients rely on pharmaceutical preparations of the Zn-insulin hexamer, which act as stable forms of the biologically active monomeric insulin. In this study, the chromophoric chelator 2,2',2"-terpyridine (terpy) has been used as a kinetic probe of insulin hexamer stability to measure the effect of homotropic and heterotropic effectors on the dissociation kinetics of the Zn2+- and Co2+-insulin hexamer complexes. We show that the reaction between terpy and the R-state-bound metal ion is limited by the T3R3 <==> T6 or R6 <==> T3R3 conformational transition steps and the dissociation of one anionic ligand, or one anionic ligand and three phenolic ligand molecules, respectively, for T3R3 and R6. Consequently, because the activation energies of these steps are dominated by the ground-state stabilization energy of the R-state species, the kinetic stabilization of the insulin hexamer toward terpy-induced dissociation is linked to the thermodynamic stabilization of the hexamer. The mass action effect of anion binding and, foremost, of phenolic ligand binding provides the major mechanism of stabilization, resulting in the tightening of the tertiary and quaternary hexamer structures. Using this kinetic method, we show that the R6 conformation of Zn-insulin in the presence of Cl- ion and resorcinol is > 1.5 million-fold more stable than the T3 units of T6 and T3R3 and > 70,000-fold more stable than the R3 unit of T3R3. Furthermore, the stabilization effect is correlated with the affinity of the ligands: the tighter the binding, the slower the reaction between terpy and R-state-bound metal ion. These concepts provide a new basis for the pharmaceutical improvement of the physicochemical stability of formulations both for native insulin and for fast-acting monomeric insulin analogues through ligand-mediated allosteric interactions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153424     DOI: 10.1021/bi963038q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Intrinsic fibrillation of fast-acting insulin analogs.

Authors:  R Jeremy Woods; Javier Alarcón; Elaine McVey; Ronald J Pettis
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

2.  Biochemical and physiological properties of a novel series of long-acting insulin analogs obtained by acylation with cholic acid derivatives.

Authors:  Ib Jonassen; Svend Havelund; Ulla Ribel; Anne Plum; Mette Loftager; Thomas Hoeg-Jensen; Aage Volund; Jan Markussen
Journal:  Pharm Res       Date:  2006-12-21       Impact factor: 4.200

3.  Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface.

Authors:  Emília Antolíková; Lenka Žáková; Johan P Turkenburg; Christopher J Watson; Ivona Hančlová; Miloslav Šanda; Alan Cooper; Tomáš Kraus; A Marek Brzozowski; Jiří Jiráček
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

4.  Self-association properties of monomeric insulin analogs under formulation conditions.

Authors:  J P Richards; M P Stickelmeyer; D B Flora; R E Chance; B H Frank; M R DeFelippis
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

5.  Interactions Between Peptide and Preservatives: Effects on Peptide Self-Interactions and Antimicrobial Efficiency In Aqueous Multi-Dose Formulations.

Authors:  P Heljo; A Ross; I E Zarraga; A Pappenberger; H-C Mahler
Journal:  Pharm Res       Date:  2015-04-18       Impact factor: 4.200

6.  Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions.

Authors:  Nischay K Rege; Nalinda P Wickramasinghe; Alisar N Tustan; Nelson F B Phillips; Vivien C Yee; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2018-06-07       Impact factor: 5.157

7.  Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).

Authors:  Yinuo Pang; Masahiro Sakagami; Peter R Byron
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

8.  Structural signatures of the complex formed between 3-nitro-4-hydroxybenzoate and the Zn(II)-substituted R(6) insulin hexamer.

Authors:  Helle Birk Olsen; Melissa R Leuenberger-Fisher; Webe Kadima; Dan Borchardt; Niels C Kaarsholm; Michael F Dunn
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

Review 9.  Controlled release of biologics for the treatment of type 2 diabetes.

Authors:  Caslin A Gilroy; Kelli M Luginbuhl; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2015-12-02       Impact factor: 9.776

10.  Biophysical optimization of a therapeutic protein by nonstandard mutagenesis: studies of an iodo-insulin derivative.

Authors:  Vijay Pandyarajan; Nelson B Phillips; Gabriela P Cox; Yanwu Yang; Jonathan Whittaker; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.